Invesco’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,709
| Closed | -$81.4K | – | 3913 |
|
|
2024
Q2 | $81.4K | Buy |
+35,709
| New | +$136K | ﹤0.01% | 3777 |
|
|
2023
Q4 | – | Sell |
-20,697
| Closed | -$29.8K | – | 3910 |
|
|
2023
Q3 | $29.8K | Buy |
20,697
+6,772
| +49% | +$13.1K | ﹤0.01% | 3832 |
|
|
2023
Q2 | $34.7K | Buy |
13,925
+1,010
| +8% | +$2.76K | ﹤0.01% | 3837 |
|
|
2023
Q1 | $34.6K | Buy |
12,915
+1,790
| +16% | +$8.6K | ﹤0.01% | 3777 |
|
|
2022
Q4 | $60.4K | Sell |
11,125
-101,936
| -90% | -$854K | ﹤0.01% | 3894 |
|
|
2022
Q3 | $1.41M | Buy |
+113,061
| New | +$1.29M | ﹤0.01% | 2784 |
|
|
2022
Q2 | – | Sell |
-16,108
| Closed | -$122K | – | 4176 |
|
|
2022
Q1 | $122K | Sell |
16,108
-8,561
| -35% | -$81.2K | ﹤0.01% | 3850 |
|
|
2021
Q4 | $252K | Sell |
24,669
-2,261
| -8% | -$28.8K | ﹤0.01% | 3692 |
|
|
2021
Q3 | $362K | Buy |
26,930
+2,716
| +11% | +$44.3K | ﹤0.01% | 3573 |
|
|
2021
Q2 | $531K | Buy |
24,214
+5,907
| +32% | +$131K | ﹤0.01% | 3391 |
|
|
2021
Q1 | $441K | Sell |
18,307
-657,173
| -97% | -$15.3M | ﹤0.01% | 3388 |
|
|
2020
Q4 | $12.2M | Buy |
675,480
+347,896
| +106% | +$5.2M | ﹤0.01% | 1704 |
|
|
2020
Q3 | $3.78M | Buy |
327,584
+84,678
| +35% | +$1.4M | ﹤0.01% | 2136 |
|
|
2020
Q2 | $5.89M | Sell |
242,906
-26,676
| -10% | -$441K | ﹤0.01% | 1907 |
|
|
2020
Q1 | $2.97M | Buy |
269,582
+37,170
| +16% | +$694K | ﹤0.01% | 2175 |
|
|
2019
Q4 | $6.14M | Sell |
232,412
-14,800
| -6% | -$346K | ﹤0.01% | 2040 |
|
|
2019
Q3 | $5.63M | Buy |
247,212
+207,790
| +527% | +$6.55M | ﹤0.01% | 2058 |
|
|
2019
Q2 | $1.21M | Sell |
39,422
-31,001
| -44% | -$653K | ﹤0.01% | 2963 |
|
|
2019
Q1 | $1.17M | Buy |
70,423
+37,307
| +113% | +$708K | ﹤0.01% | 2934 |
|
|
2018
Q4 | $634K | Sell |
33,116
-105,489
| -76% | -$3.95M | ﹤0.01% | 3182 |
|
|
2018
Q3 | $7.25M | Buy |
138,605
+89,633
| +183% | +$4.89M | ﹤0.01% | 1929 |
|
|
2018
Q2 | $2.13M | Buy |
+48,972
| New | +$2.1M | ﹤0.01% | 2716 |
|
Invesco's GTHX Position: Q3 2024 in Review
Invesco sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 35,709 shares — an estimated $81.4K sold.
Invesco first reported a position in GTHX in Q2 2018 and held it in 22 quarters. The position peaked at $12.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Invesco reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Invesco sold 35,709 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $81.4K.
- Invesco first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
- Invesco's G1 Therapeutics, Inc. Common Stock position peaked at $12.2M in Q4 2020.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.